{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:06:23Z","timestamp":1779944783730,"version":"3.53.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Parkinson\u2019s disease is a progressive neurodegenerative condition, and unfortunately, there are currently no treatments available that can halt or slow down its progression. However, recent research on intensive and multidisciplinary rehabilitation shows great promise, indicating that vigorous exercise may offer benefits to patients. This study is a randomized, single-blind, controlled, two-arm trial comparing an intensive outpatient multidisciplinary rehabilitation program with a home-based self-administered stretching program in Persons with Parkinson\u2019s disease (PwPD). This study aims to assess the effects of an intensive rehabilitation program compared to a home-based self-treatment plan on the serum expression of four molecular biomarkers: brain-derived neurotrophic factor (BDNF), total\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -synuclein, miR-223-3p, and miR-7-1-5p in PwPD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We enrolled seventy PwPD in mild-to-moderate stages (average age: 71.15\u202f\u00b1\u202f16.19\u202fyears, disease duration: 7.67\u202f\u00b1\u202f5.61\u202fyears; UPDRS: 38.06\u202f\u00b1\u202f13.07). Out of these, 36 participants (19 males and 17 females) were assigned to an outpatient daily intensive multidisciplinary rehabilitation treatment (EXP-PwPD), while 34 (22 males and 12 females) participated in a home-based self-treatment stretching program (CTRL-PwPD). Serum samples were taken at baseline (T0), at the end of the intervention period (T1, 6\u202fweeks after T0), and at T2 (3\u202fmonths after T1). We measured the protein concentrations (BDNF and\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -synuclein) and circulating miRNAs (miR-223-3p and miR-7-1-5p) in the serum, and compared results between the groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>\n                      The intensive rehabilitation program led to a significant increase in serum BDNF and\n                      <jats:italic>\u03b1<\/jats:italic>\n                      -synuclein expression. Notably, the rise in serum \u03b1-synuclein was dependent on exercise, returning to baseline concentration at T2, while serum BDNF remained significantly elevated even 2\u202fmonths post-program completion (T2) (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03). Among the miRNAs studied, miR-7-1-5p reflected the pattern of BDNF, showing a notable increase after intensive rehabilitation (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.05) and persistence at follow-up (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.04). There were no significant changes for miR-223-3p. In conclusion, this study indicates that intensive rehabilitation can modify circulating biomarkers in PD. Our findings indicate that intensive exercise induces a sustained elevation of serum BDNF and miR-7-1-5p, reflecting enhanced neuroplastic and neurotrophic activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>\n                      , identifier: NCT05452655.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fncel.2026.1760593","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:51:54Z","timestamp":1779943914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensive multidisciplinary rehabilitation modulates serum \u03b1-synuclein and miRNA expression in Parkinson\u2019s disease: preliminary results of a randomized study"],"prefix":"10.3389","volume":"20","author":[{"given":"Simone","family":"Agostini","sequence":"first","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Meloni","sequence":"additional","affiliation":[{"name":"Neurology Unit, Azienda Ospedaliero-Universitaria","place":["Cagliari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mancuso","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Nuzzi","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferraro","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Salvatore","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Arcuri","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Castagna","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Navarro","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Lea","family":"Saibene","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Clerici","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi","place":["Milan, Italy"]},{"name":"Department of Pathophysiology and Transplantation, University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"105185","DOI":"10.1016\/j.nbd.2020.105185","article-title":"Oligomeric \u03b1-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease","volume":"148","author":"Agliardi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/vaccines9070686","article-title":"A possible role for HSV-1-specific humoral response and PILRA rs1859788 polymorphism in the pathogenesis of Parkinson\u2019s disease","volume":"9","author":"Agostini","year":"2021","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.1007\/s11033-020-05862-0","article-title":"COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression","volume":"47","author":"Agostini","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1139\/cjpp-2015-0322","article-title":"The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson's disease subjects","volume":"94","author":"Angelucci","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","article-title":"Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta","volume":"25","author":"Baquet","year":"2005","journal-title":"J. Neurosci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1038\/s41598-019-43978-x","article-title":"The effects of regular exercise on circulating cardiovascular-related MicroRNAs","volume":"9","author":"Barber","year":"2019","journal-title":"Sci. Rep."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/s415","article-title":"Partkinson\u2019s disease: a review","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci. Sch."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"891508","DOI":"10.3389\/fmolb.2022.891508","article-title":"\u03b1-Synuclein in the synaptic vesicle liquid phase: active player or passive bystander?","volume":"9","author":"Brodin","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neulet.2018.05.009","article-title":"MicroRNA-7 facilitates the degradation of alpha-synuclein and its aggregates by promoting autophagy","volume":"678","author":"Choi","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/biom13050865","article-title":"Serum and exosomal miR-7-1-5p and miR-223-3p as possible biomarkers for Parkinson\u2019s disease","volume":"13","author":"Citterio","year":"2025","journal-title":"Biomolecules"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson\u2019s disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/glia.23645","article-title":"Glial HMOX1 expression promotes central and peripheral \u03b1-synuclein dysregulation and pathogenicity in parkinsonian mice","volume":"67","author":"Cressatti","year":"2019","journal-title":"Glia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3892\/mmr.2021.12257","article-title":"Expression levels of specific microRNAs are increased after exercise and are associated with cognitive improvement in Parkinson's disease","volume":"24","author":"Da Silva","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"738333","DOI":"10.3389\/fphys.2021.738333","article-title":"Exercise training and circulating small extracellular vesicles: appraisal of methodological approaches and current knowledge","volume":"12","author":"Darragh","year":"2021","journal-title":"Front. Physiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s10571-020-01027-6","article-title":"Role of microgliosis and NLRP3 Inflammasome in Parkinson's disease pathogenesis and therapy","volume":"42","author":"de Araujo","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1086487","DOI":"10.3389\/fnagi.2023.1086487","article-title":"Whole body-electromyostimulation effects on serum biomarkers, physical performances and fatigue in Parkinson's patients: a randomized controlled trial","volume":"15","author":"Di Cagno","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"111058","DOI":"10.1016\/j.celrep.2022.111058","article-title":"Treadmill exercise reduces \u03b1-synuclein spreading via PPAR\u03b1","volume":"40","author":"Dutta","year":"2022","journal-title":"Cell Rep."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1136\/jnnp-2017-316437","article-title":"Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study","volume":"89","author":"Ferrazzoli","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/1545968315600272","article-title":"Intensive rehabilitation enhances lymphocyte BDNF-TrkB signaling in patients with Parkinson's disease","volume":"30","author":"Fontanesi","year":"2016","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0121251","DOI":"10.1371\/journal.pone.0121251","article-title":"Differences in muscle strength in parkinsonian patients affected on the right and left side","volume":"10","author":"Frazzitta","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1545968313508474","article-title":"Intensive rehabilitation increases BDNF serum levels in parkinsonian patients: a randomized study","volume":"28","author":"Frazzitta","year":"2014","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/mds.10473","article-title":"The unified Parkinson\u2019s disease rating scale (UPDRS): status and recommendations","volume":"18","author":"Goetz","year":"2003","journal-title":"Mov. Disord."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society\u2013sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JPD-230117","article-title":"Delivering multidisciplinary rehabilitation Care in Parkinson's disease: an international consensus statement","volume":"14","author":"Goldman","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.3390\/ijerph20095671","article-title":"Co-creating a feasible, acceptable and safe home-based high-intensity interval training Programme for people with Parkinson's: the HIIT-Home4Parkinson's study","volume":"20","author":"Harpham","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.parkreldis.2015.10.006","article-title":"Minimal clinically important difference on the motor examination part of MDS-UPDRS","volume":"21","author":"Horvath","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","article-title":"Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra","volume":"166","author":"Howells","year":"2000","journal-title":"Exp. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/brainsci14030194","article-title":"Effects and mechanisms of exercise on brain-derived neurotrophic factor (BDNF) levels and clinical outcomes in people with Parkinson's disease: a systematic review and Meta-analysis","volume":"14","author":"Kaagman","year":"2024","journal-title":"Brain Sci."},{"key":"ref32","first-page":"S382","article-title":"European guidelines for physiotherapy in Parkinson\u2019s disease","volume":"28","author":"Keus","year":"2013","journal-title":"Mov. Disord."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"149540","DOI":"10.1016\/j.brainres.2025.149540","article-title":"Treadmill exercise mitigates rotenone-induced neuroinflammation and \u03b1-synuclein level in a mouse model of Parkinson\u2019s disease","volume":"1854","author":"Kumar","year":"2025","journal-title":"Brain Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/NPT.0000000000000249","article-title":"A high-intensity exercise boot camp for persons with Parkinson disease: a phase II, pragmatic, randomized clinical trial of feasibility, safety, signal of efficacy, and disease mechanisms","volume":"43","author":"Landers","year":"2019","journal-title":"J. Neurol. Phys. Ther."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.chemosphere.2019.05.064","article-title":"Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor\/\u03b1-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling","volume":"233","author":"Li","year":"2019","journal-title":"Chemosphere"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4103\/1673-5374.293151","article-title":"Anxiety, depression, and quality of life in Parkinson's disease: the implications of multidisciplinary treatment","volume":"16","author":"Lo Buono","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41531-025-01042-8","article-title":"Aerobic exercise-induced changes in fluid biomarkers in Parkinson's disease","volume":"11","author":"Luthra","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"9393","DOI":"10.1038\/s41598-019-45687-x","article-title":"Circulatory miR-223-3p discriminates between Parkinson's and Alzheimer's patients","volume":"9","author":"Mancuso","year":"2019","journal-title":"Sci. Rep."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"585988","DOI":"10.3389\/fnagi.2020.585988","article-title":"Effectiveness of an innovative cognitive treatment and Telerehabilitation on subjects with mild cognitive impairment: a multicenter, randomized, active-controlled study","volume":"12","author":"Manenti","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"626041","DOI":"10.3389\/fneur.2021.626041","article-title":"Functional and cognitive improvement after an intensive inpatient multidisciplinary rehabilitation program in mild to severe Parkinson's disease: a retrospective and observational study","volume":"12","author":"Meloni","year":"2021","journal-title":"Front. Neurol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/biom14101241","article-title":"Exercise, neuroprotective Exerkines, and Parkinson's disease: a narrative review","volume":"14","author":"Mitchell","year":"2024","journal-title":"Biomolecules."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbrc.2007.04.108","article-title":"Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage","volume":"358","author":"Nakai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s40520-019-01353-w","article-title":"Comparing the influence of exercise intensity on brain-derived neurotrophic factor serum levels in people with Parkinson's disease: a pilot study","volume":"32","author":"O'Callaghan","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/s0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"102089","DOI":"10.1016\/j.arr.2023.102089","article-title":"Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson's disease: a systematic review and meta-analysis","volume":"92","author":"Rotondo","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e0309405","DOI":"10.1371\/journal.pone.0309405","article-title":"Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson\u2019s disease: study protocol for a phase III randomized controlled clinical trial","volume":"19","author":"Saibene","year":"2024","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2147\/PPA.S135551","article-title":"A randomized trial of individual versus group-format exercise and self-management in individuals with Parkinson's disease and comorbid depression","volume":"11","author":"Sajatovic","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00415-009-5357-2","article-title":"Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease","volume":"257","author":"Scalzo","year":"2010","journal-title":"J. Neurol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2014.09.049","article-title":"The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease","volume":"302","author":"Schapansky","year":"2015","journal-title":"Neuroscience"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0153200","DOI":"10.1371\/journal.pone.0153200","article-title":"Comparison of methodologies to detect low levels of hemolysis in serum for accurate assessment of serum microRNAs","volume":"11","author":"Shah","year":"2016","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"576569","DOI":"10.3389\/fneur.2020.576569","article-title":"Non-pharmacological treatment challenges in early Parkinson's disease for axial and cognitive symptoms: a Mini review","volume":"11","author":"Sharpe","year":"2020","journal-title":"Front. Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s40263-013-0053-2","article-title":"Management of motor and non-motor symptoms in Parkinson\u2019s disease","volume":"27","author":"Sprenger","year":"2013","journal-title":"CNS Drugs"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/jcm9010184","article-title":"The Immunomodulary effects of systematic exercise in older adults and people with Parkinson's disease","volume":"9","author":"Szymura","year":"2020","journal-title":"J. Clin. Med."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000013218","article-title":"Long-term effect of regular physical activity and exercise habits in patients with early Parkinson disease","volume":"98","author":"Tsukita","year":"2022","journal-title":"Neurology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e0190160","DOI":"10.1371\/journal.pone.0190160","article-title":"Running wheel exercise reduces \u03b1-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson\u2019s disease","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2026.1760593\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:52:08Z","timestamp":1779943928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2026.1760593\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":59,"alternative-id":["10.3389\/fncel.2026.1760593"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2026.1760593","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1760593"}}